Urogen Pharma Ltd. (URGN) — DEF 14A Filings
All DEF 14A filings from Urogen Pharma Ltd.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
UroGen Pharma Details Executive Equity Awards Ahead of Shareholder Vote
— Jul 15, 2025 Risk: medium
UroGen Pharma Ltd.'s DEF 14A filing, dated July 15, 2025, primarily focuses on executive compensation and governance matters for the fiscal year ended December -
UroGen Pharma Shareholder Meeting: Director Elections & Equity Plan
— Jul 1, 2024 Risk: medium
UroGen Pharma Ltd. is holding its 2024 Annual Meeting of Shareholders on August 7, 2024. Shareholders will vote on the election of two Class II directors, Mr. R
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX